All articles
Publications
Clinical trials
Drugs
Diseases

Catalogue

Loading Lonevi

Please wait while we prepare your medical assistant...

Your health records in one place

Products

Health Score test
For partners
Technical specification
Articles
Science
Publications
Clinical trials
Drugs
Diseases
Manifesto
Shop
Shop catalogue

Legal

Terms of Service
Privacy Policy
Medical Data Consent
Cookie Policy
Ethics policy

Connect

Telegram channel
Support: questions about the service

Language

Lonevi is an informational service. We are not a medical organization, do not provide diagnoses or prescribe treatment. Any information in the service is educational. For health concerns, consult a licensed physician.

Do not use the service for acute symptoms — call your local emergency number.

© 2026 DreamLight LLP. All rights reserved.Part of VARDIX Group

Developed by DreamLight Labs

← All of Science

Clinical trials

Studies registered on ClinicalTrials.gov, anchored to the NCT number.

Evidence

Any
Very low
Low
Moderate
High

Closeness to humans

Any
Cells in vitro
Animals
Early human trials
Proven efficacy in humans

Axis

Any
Genomic instability
Telomere attrition
Epigenetic alterations
Loss of proteostasis
Disabled macroautophagy
Deregulated nutrient sensing
Mitochondrial dysfunction
Cellular senescence
Stem cell exhaustion
Altered intercellular communication
Chronic inflammation
Dysbiosis

Order

Newest
By name
Strongest evidence
Closest to humans

1 card

Clinical trialPhase 2
PURIFY-TIMI 81 (YN001)
NCT07521007
Phase 2b, N≈456, randomized double-blind placebo-controlled; primary endpoint relative change coronary noncalcified plaque volume.
1 news item